Here we highlight axSpA manifestations, compare treatment recommendations and summarize the ASAS-EULAR treatment recommendations. (©Illustrart/Shutterstock.com)
7 Treatment Guidelines for Knee and Hip Replacement Surgery
In this slideshow, we highlight newly released treatment recommendations for rheumatic disease patients undergoing total hip or total knee arthroplasty.
New Antirheumatic Drug Guidelines for Hip and Knee Arthroplasty
Rheumatic patients are more prone to complications post knee and hip surgery. Two physician associations have penned new treatment guidelines.
Does Fibromyalgia Mask Spondyloarthritis?
With clinical overlap, study findings suggest vigilance and an active search for underlying inflammatory disorders.
Some Early Spondyloarthritis Features More Definitive than Others
Sacroiliitis on MRI and peripheral arthritis appear to be the best indicators of disease in this group, researchers report.
Review: Axial Spondyloarthritis Treatment Guidelines
Updated EULAR guidelines for axial spondyloarthritis raise more questions than answers about biologic therapies and treat-to-target strategies, a review suggests.
Here’s What You Should Know about Axial Spondyloarthritis
Chronic back pain, arthritis and enthesitis are among common axSpA manifestations, but no two patients are alike. Here, we highlight key presentations.
Axial Spondyloarthritis Guidelines Updated and Simplified
EULAR-ASAS have updated the 2010 guidelines for axSpA emphasizing treat to target, tapering and for the first time, cost considerations.
Axial Spondyloarthritis Treatment Recommendations
In this slideshow, we highlight the 13 ASAS-EULAR treatment management guidelines for axial spondyloarthritis.
Interleukin Inhibitors in Brief
Agents that target the TH17-interleukin pathway show promise in psoriatic arthritis, as alternatives for patients who don't benefit from TNFα blockers. This slide show describes their mode of action and potential.
By clicking Accept, you agree to become a member of the UBM Medica Community.